What are the effects of spironolactone on vitamin D, estriol, progesterone, triiodothyronine (T3), and thyroxine (T4) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Effects of Spironolactone on Vitamin D, Estriol, Progesterone, T3, and T4

Spironolactone can significantly affect hormone levels including progesterone, thyroid hormones, and potentially vitamin D, with its antagonistic effects on the androgen and progesterone receptors being most clinically relevant. 1

Effects on Specific Hormones

Progesterone

  • Spironolactone acts as an antagonist on progesterone receptors 1
  • This antagonism can lead to menstrual irregularities in 15-30% of female patients
  • The effect is dose-dependent, with higher risk (RR 4.12,95% CI 3.27-5.19) at doses of 200mg/day 1

Thyroid Hormones (T3 and T4)

  • Spironolactone can transiently decrease serum T3 and T4 levels 2
  • Research in male rats showed significant decreases in T3 and T4 at weeks 2 and 4 of treatment, though levels returned to normal by week 13 2
  • The mechanism appears to be increased hepatic clearance of T4 through increased uridine diphosphate glucuronosyl transferase activity 2
  • In humans, spironolactone may exert an unfavorable effect on thyroid autoimmunity in men with Hashimoto's thyroiditis, increasing thyroid antibody titers 3
  • The drug produced a neutral effect on serum levels of thyrotropin and free thyroid hormones in euthyroid men 3

Vitamin D

  • Spironolactone treatment has been associated with decreased 25-hydroxyvitamin D levels in men with Hashimoto's thyroiditis 3
  • The effect on vitamin D may be related to spironolactone's influence on bone metabolism through its anti-aldosteronergic effects 4

Estriol

  • While specific data on estriol is limited in the evidence provided, spironolactone has known anti-androgenic properties that can indirectly affect estrogen metabolism
  • These anti-androgenic effects can lead to gynecomastia or breast tenderness in 10% of men 5, 1

Clinical Implications and Monitoring

Dosing Considerations

  • Starting doses for various conditions:
    • Heart failure: 12.5-25 mg once daily (target 25-50 mg) 1, 4
    • Acne: 50-100 mg daily 4
    • Primary aldosteronism: 50-100 mg daily (up to 300-400 mg if necessary) 4

Monitoring Recommendations

  • Regular monitoring of serum potassium and renal function is essential 1, 4
  • Potassium monitoring is particularly important in:
    • Elderly patients
    • Patients with renal or hepatic dysfunction
    • Patients taking ACE inhibitors, ARBs, NSAIDs, or digoxin 4
  • Consider monitoring thyroid function in patients with pre-existing thyroid conditions 3, 2
  • Monitor for menstrual irregularities in women 1
  • Watch for signs of gynecomastia or breast tenderness, particularly in men 1, 5

Common Side Effects

  • Menstrual irregularities (15-30% of female patients) 1
  • Breast tenderness (3-5%) or gynecomastia (10% in men) 1, 5
  • Dizziness (3-4%), nausea (2-4%), headache (2%) 1
  • Polyuria (1-2%) and fatigue (1-2%) 1

Special Considerations

Contraindications

  • Hyperkalemia 1
  • Severe renal insufficiency 1
  • Pregnancy (category C) 1
  • Concomitant use of other potassium-sparing diuretics 4

Alternative Options

  • Eplerenone is an alternative mineralocorticoid receptor antagonist with fewer hormonal side effects but less potency 4
  • For women with menstrual irregularities on spironolactone, concomitant use of a combined oral contraceptive or hormonal intrauterine device may minimize this side effect 1

Understanding these hormonal effects is crucial when prescribing spironolactone, particularly in patients with pre-existing endocrine disorders or those at risk for hormonal imbalances.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bone Health Effects of Spironolactone

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.